| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | fluvastatin | CTRPv2 | pan-cancer | AAC | -0.11 | 0.003 |
| mRNA | AT-7519 | GDSC1000 | pan-cancer | AAC | -0.092 | 0.003 |
| mRNA | Pazopanib | GDSC1000 | pan-cancer | AAC | 0.11 | 0.003 |
| mRNA | Panobinostat | CCLE | pan-cancer | AAC | 0.12 | 0.004 |
| mRNA | THZ-2-102-1 | GDSC1000 | pan-cancer | AAC | -0.09 | 0.005 |
| mRNA | YM-155 | CTRPv2 | pan-cancer | AAC | -0.11 | 0.006 |
| mRNA | BMS-754807 | CTRPv2 | pan-cancer | AAC | 0.098 | 0.006 |
| mRNA | Oxaliplatin | CTRPv2 | pan-cancer | AAC | 0.092 | 0.006 |
| mRNA | Bryostatin 1 | GDSC1000 | pan-cancer | AAC | 0.1 | 0.007 |
| mRNA | Cetuximab | GDSC1000 | pan-cancer | AAC | 0.094 | 0.007 |